In addition, serum GFAP levels were increased in patients with severe brain injury on admission and significantly predicted neurological outcomes at six months [22], and elevated levels of serum GFAP were significantly correlated with the extent of brain damage in ischemic stroke patients [15]. This evidence concerns the gene GFAP and ischemic stroke.